Cargando…

Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles

All-hydrocarbon, i, i+7 stapled peptide inhibitors of the p53-Mdm2 interaction have emerged as promising new leads for cancer therapy. Typical chemical synthesis via olefin metathesis results in the formation of both E- and Z-isomers, an observation that is rarely disclosed but may be of importance...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuen, Tsz Ying, Brown, Christopher J., Xue, Yuezhen, Tan, Yaw Sing, Ferrer Gago, Fernando J., Lee, Xue Er, Neo, Jin Yong, Thean, Dawn, Kaan, Hung Yi Kristal, Partridge, Anthony W., Verma, Chandra S., Lane, David P., Johannes, Charles W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Chemistry 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610352/
https://www.ncbi.nlm.nih.gov/pubmed/31316744
http://dx.doi.org/10.1039/c9sc01456j
_version_ 1783432490451468288
author Yuen, Tsz Ying
Brown, Christopher J.
Xue, Yuezhen
Tan, Yaw Sing
Ferrer Gago, Fernando J.
Lee, Xue Er
Neo, Jin Yong
Thean, Dawn
Kaan, Hung Yi Kristal
Partridge, Anthony W.
Verma, Chandra S.
Lane, David P.
Johannes, Charles W.
author_facet Yuen, Tsz Ying
Brown, Christopher J.
Xue, Yuezhen
Tan, Yaw Sing
Ferrer Gago, Fernando J.
Lee, Xue Er
Neo, Jin Yong
Thean, Dawn
Kaan, Hung Yi Kristal
Partridge, Anthony W.
Verma, Chandra S.
Lane, David P.
Johannes, Charles W.
author_sort Yuen, Tsz Ying
collection PubMed
description All-hydrocarbon, i, i+7 stapled peptide inhibitors of the p53-Mdm2 interaction have emerged as promising new leads for cancer therapy. Typical chemical synthesis via olefin metathesis results in the formation of both E- and Z-isomers, an observation that is rarely disclosed but may be of importance in targeting PPI. In this study, we evaluated the effect of staple geometry on the biological activity of five p53-reactivating peptides. We also present strategies for the modulation of the E/Z ratio and attainment of the hydrogenated adduct through repurposing of the metathesis catalyst.
format Online
Article
Text
id pubmed-6610352
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-66103522019-07-15 Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles Yuen, Tsz Ying Brown, Christopher J. Xue, Yuezhen Tan, Yaw Sing Ferrer Gago, Fernando J. Lee, Xue Er Neo, Jin Yong Thean, Dawn Kaan, Hung Yi Kristal Partridge, Anthony W. Verma, Chandra S. Lane, David P. Johannes, Charles W. Chem Sci Chemistry All-hydrocarbon, i, i+7 stapled peptide inhibitors of the p53-Mdm2 interaction have emerged as promising new leads for cancer therapy. Typical chemical synthesis via olefin metathesis results in the formation of both E- and Z-isomers, an observation that is rarely disclosed but may be of importance in targeting PPI. In this study, we evaluated the effect of staple geometry on the biological activity of five p53-reactivating peptides. We also present strategies for the modulation of the E/Z ratio and attainment of the hydrogenated adduct through repurposing of the metathesis catalyst. Royal Society of Chemistry 2019-05-30 /pmc/articles/PMC6610352/ /pubmed/31316744 http://dx.doi.org/10.1039/c9sc01456j Text en This journal is © The Royal Society of Chemistry 2019 https://creativecommons.org/licenses/by-nc/3.0/This article is freely available. This article is licensed under a Creative Commons Attribution Non Commercial 3.0 Unported Licence (CC BY-NC 3.0)
spellingShingle Chemistry
Yuen, Tsz Ying
Brown, Christopher J.
Xue, Yuezhen
Tan, Yaw Sing
Ferrer Gago, Fernando J.
Lee, Xue Er
Neo, Jin Yong
Thean, Dawn
Kaan, Hung Yi Kristal
Partridge, Anthony W.
Verma, Chandra S.
Lane, David P.
Johannes, Charles W.
Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles
title Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles
title_full Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles
title_fullStr Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles
title_full_unstemmed Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles
title_short Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles
title_sort stereoisomerism of stapled peptide inhibitors of the p53-mdm2 interaction: an assessment of synthetic strategies and activity profiles
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610352/
https://www.ncbi.nlm.nih.gov/pubmed/31316744
http://dx.doi.org/10.1039/c9sc01456j
work_keys_str_mv AT yuentszying stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles
AT brownchristopherj stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles
AT xueyuezhen stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles
AT tanyawsing stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles
AT ferrergagofernandoj stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles
AT leexueer stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles
AT neojinyong stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles
AT theandawn stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles
AT kaanhungyikristal stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles
AT partridgeanthonyw stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles
AT vermachandras stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles
AT lanedavidp stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles
AT johannescharlesw stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles